Delivery Order SPE2DE24DA017-SPE2D626F490H
- Not listed
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $7,656.51 on September 3, 2025, for KL 1.8 Fibertak shoulder products. This fixed-price delivery order with economic price adjustment is set to be completed by September 9, 2025, and will be performed in Naples, Florida. The award was made by the Defense Logistics Agency's Medical Supply Chain, which procures medical devices and equipment...
- Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a fixed-price delivery order valued at $11,592.40 for KL 1.8 Fibertak shoulder products. The contract was awarded on September 5, 2025, with an ultimate completion date of September 10, 2025, and will be performed in Naples, Florida. This delivery order was issued without a set-aside designation, reflecting Arthrex's competitive position in the federal marketplace....
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $38,280.66 for KL 1.8 Fibertak shoulder products by the Defense Logistics Agency's Medical Supply Chain on November 17, 2025. This fixed-price delivery order with economic price adjustment will be completed by November 20, 2025, and will be performed at Arthrex's Naples, Florida facility. The award carries no set-aside...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order on August 11, 2025, for KL 1.8 Fibertak shoulder products with a ceiling value of $7,697.70. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 14, 2025, and will be performed in Naples, Florida. The award was issued without a set-aside designation, reflecting Arthrex's strong competitive position in the federal...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic surgical technologies headquartered in Naples, Florida, was awarded a delivery order for KL 1.8 Fibertak shoulder products valued at $9,799.80. The contract, awarded December 10, 2025, with an ultimate completion date of December 15, 2025, was issued without set-aside designation and carries a fixed-price structure with economic price adjustment provisions. The award is funded through the Defense Logistics Agency's Medical...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $2,422.90 for KL 1.8 Fibertak shoulder products on May 6, 2025, with completion targeted for May 9, 2025. The award was issued under a fixed-price contract with economic price adjustment terms and represents a non-set-aside procurement. The Defense Logistics Agency's Medical Supply Chain division funded this delivery order, which will be performed at Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,422.90 on August 25, 2025, for KL 1.8 Fibertak shoulder products. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 28, 2025, and will be performed in Naples, Florida. The award was issued without a set-aside designation, reflecting Arthrex's competitive standing in the federal marketplace. The delivery...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $15,907.00 for KL 1.8 Fibertak shoulder products. The contract, awarded on April 28, 2025, with an ultimate completion date of May 1, 2025, is a fixed-price delivery order with economic price adjustment provisions. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a Department of Defense entity, and...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a delivery order valued at $7,546 on August 22, 2025, with an ultimate completion date of August 27, 2025. The contract, issued under a fixed-price arrangement with economic price adjustment provisions, covers KL 1.8 Fibertak shoulder products. This delivery order was funded through the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency, with performance taking place in...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $4,845.80 on July 29, 2025, for KL 1.8 Fibertak shoulder products. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 1, 2025, and will be performed in Naples, Florida. The award was issued without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The funding...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F490HDelivery Order
Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has been awarded a delivery order valued at $7,268.70 for KL 1.8 Fibertak shoulder products under a fixed-price contract with economic price adjustment provisions. The award, issued on November 25, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, reflecting Arthrex's strong competitive position in federal procurement. Performance will be completed at the company's Naples, Florida facility, and the delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency responsible for supplying the Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order is issued under Arthrex's existing Indefinite Delivery Contract SPE2DE24D0020 with the Defense Logistics Agency's Medical Supply Chain, a comprehensive master contract valued at $471 billion effective from June 11, 2024, through September 1, 2029. This IDC authorizes procurement of Arthrex's full spectrum of orthopedic products and surgical technologies, including surgical implants, arthroscopic instruments, joint replacement technologies, and biologics supporting VA medical centers and Department of Defense healthcare facilities nationwide. The contract structure enables rapid procurement of advanced orthopedic solutions to support surgical procedures for veteran and active-duty patient populations across multiple orthopedic specialties, with Arthrex serving as the prime contractor with no identified subcontractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 11/24/25 |